PE

PetMed Express Inc

PETS
Accountable AI Logo

PetMed Express Inc AI Insights

Informational only. Not investment advice.
As of 2025-12-11

Snapshot

  • Goodwill of 26.7M is 31% of equity (85M) with 1.2M impairment charge TTM - intangible asset risk elevated[Goodwill]
  • Revenue declined -9% over 5Y while industry median grew +9% - structural share loss in pet pharmacy market[Total Revenue 5Y Growth]
  • EV of 7.8M vs market cap 61.5M - 54.7M net cash (89% of market cap) provides downside floor[Enterprise Value]

Watch Triggers

  • Total Revenue: Quarterly revenue stabilizes or grows YoYRevenue decline is core thesis risk - stabilization signals competitive positioning improvement
  • Cash and Equivalents: Falls below 40MAt -6.3M annual net loss, cash runway becomes critical within 6-8 quarters
  • Gross Margin: Drops below 28%30.5% gross margin already compressed - further erosion eliminates turnaround path

Bull Case

Trading at 0.27x P/S vs industry median 2.7x with 54.7M cash (89% of market cap) - extreme value if turnaround succeeds

P/S RatioCash and EquivalentsEnterprise Value

Asset turnover 1.42x vs industry median 0.27x shows capital-light model; minimal debt (1M) preserves optionality

Asset TurnoverTotal DebtDebt to Equity

Bear Case

5Y revenue decline of -9% vs industry +9% growth signals permanent market share loss to Amazon/Chewy

Total Revenue 5Y GrowthTotal Revenue

Operating margin -0.15% with negative ROIC -6.8% TTM - business model no longer generates economic value

Operating MarginROICNet Income

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
35%

Leverage PETS's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Cash burn likely to accelerate without revenue stabilization, testing 54.7M cash cushion

1-3ymed
  • Operating income -330K TTM with negative FCF -395K
  • Revenue declining -9% 5Y while opex at 69.5M
  • Current liabilities 62.8M vs current assets 78.9M
FCF TTM: -395K with capex 5.1MNet income TTM: -6.3M lossWorking capital: only 16.1M buffer
Valuation Context
Caveats

Public Strategies Rankings

See how PetMed Express Inc ranks across different investment strategies.

Leverage PETS's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2025 Accountable Finance, Inc. All rights reserved.